Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-01-06 @ 11:39 AM
Study NCT ID:
NCT04656951
Status:
RECRUITING
Last Update Posted:
2022-04-05
First Post:
2020-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
Sponsor:
Organization: